These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3043334)

  • 21. Nephrotoxicity, high frequency ototoxicity, efficacy and serum kinetics of once versus thrice daily dosing of netilmicin in patients with serious infections.
    Blaser J; Simmen HP; Thurnheer U; König C; Lüthy R
    J Antimicrob Chemother; 1995 Nov; 36(5):803-14. PubMed ID: 8626261
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Once-versus thrice-daily netilmicin combined with amoxicillin, penicillin, or vancomycin against Enterococcus faecalis in a pharmacodynamic in vitro model.
    Schwank S; Blaser J
    Antimicrob Agents Chemother; 1996 Oct; 40(10):2258-61. PubMed ID: 8891125
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synergism between cefotaxime and fosfomycin in the therapy of methicillin and gentamicin resistant Staphylococcus aureus infection in rabbits.
    Chavanet P; Muggeo E; Waldner A; Dijoux S; Caillot D; Portier H
    Eur J Clin Microbiol Infect Dis; 1990 Apr; 9(4):271-5. PubMed ID: 2351143
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical studies on the time-difference combination therapy with netilmicin and minocycline in methicillin-resistant Staphylococcus aureus infections].
    Nasu M; Goto Y; Yamasaki T; Hara K; Kohno S; Koga H; Kaku M; Tomono K; Otsubo T; Maesaki S
    Jpn J Antibiot; 1994 Oct; 47(10):1305-17. PubMed ID: 7807692
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhancement of antistaphylococcal activity of nafcillin and oxacillin by sisomicin and netilmicin.
    Watanakunakorn C; Glotzbecker C
    Antimicrob Agents Chemother; 1977 Sep; 12(3):346-8. PubMed ID: 907328
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the serum bactericidal activity of ceftriaxone/piperacillin and ceftriaxone/netilmicin.
    Machka K; Röbl M; Braveny I
    Eur J Clin Microbiol; 1986 Feb; 5(1):115-8. PubMed ID: 3084240
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Activity of indolicidin, alone or together with oxacillin, against Staphylococcus aureus and S. epidermidis].
    Walencka E; Sadowska B; Wieckowska-Szakiel M; Rózalska B
    Med Dosw Mikrobiol; 2008; 60(3):191-6. PubMed ID: 19143172
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Experimental osteomyelitis. V. Therapeutic trials with oxacillin and sisomicin alone and in combination.
    Norden CW
    J Infect Dis; 1978 Feb; 137(2):155-60. PubMed ID: 627735
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative study with enoxacin and netilmicin in a pharmacodynamic model to determine importance of ratio of antibiotic peak concentration to MIC for bactericidal activity and emergence of resistance.
    Blaser J; Stone BB; Groner MC; Zinner SH
    Antimicrob Agents Chemother; 1987 Jul; 31(7):1054-60. PubMed ID: 3116917
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative in vitro activities of LY191145, a new glycopeptide, and vancomycin against Staphylococcus aureus and Staphylococcus-infected fibrin clots.
    Kang SL; Rybak MJ
    Antimicrob Agents Chemother; 1995 Dec; 39(12):2832-4. PubMed ID: 8593034
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacodynamics of RP 59500 alone and in combination with vancomycin against Staphylococcus aureus in an in vitro-infected fibrin clot model.
    Kang SL; Rybak MJ
    Antimicrob Agents Chemother; 1995 Jul; 39(7):1505-11. PubMed ID: 7492094
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Once-daily versus thrice-daily dosing of netilmicin in combination with beta-lactam antibiotics as empirical therapy for febrile neutropenic patients.
    Rozdzinski E; Kern WV; Reichle A; Moritz T; Schmeiser T; Gaus W; Kurrle E
    J Antimicrob Chemother; 1993 Apr; 31(4):585-98. PubMed ID: 8514653
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacodynamic parameters and toxicity of netilmicin (6 milligrams/kilogram/day) given once daily or in three divided doses to cancer patients with urinary tract infection.
    Van der Auwera P; Meunier F; Ibrahim S; Kaufman L; Derde MP; Tulkens PM
    Antimicrob Agents Chemother; 1991 Apr; 35(4):640-7. PubMed ID: 2069370
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Once daily administration of netilmicin compared with thrice daily, both in combination with metronidazole, in gangrenous and perforated appendicitis.
    Fan ST; Lau WY; Teoh-Chan CH; Lau KF; Mauracher EH
    J Antimicrob Chemother; 1988 Jul; 22(1):69-74. PubMed ID: 3170392
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of intermittent versus continuous administration of netilmicin in a two-compartment in vitro model.
    Blaser J; Stone BB; Zinner SH
    Antimicrob Agents Chemother; 1985 Mar; 27(3):343-9. PubMed ID: 3922294
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Double-blind, placebo-controlled study of oxacillin combined with rifampin in the treatment of staphylococcal infections.
    Van der Auwera P; Klastersky J; Thys JP; Meunier-Carpentier F; Legrand JC
    Antimicrob Agents Chemother; 1985 Oct; 28(4):467-72. PubMed ID: 3907494
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of once-daily netilmicin to treat infants with suspected sepsis in a neonatal intensive care unit.
    Brooks JR; Marlow N; Reeves BC; Millar MR
    Biol Neonate; 2004; 86(3):170-5. PubMed ID: 15237240
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lysostaphin treatment of experimental methicillin-resistant Staphylococcus aureus aortic valve endocarditis.
    Climo MW; Patron RL; Goldstein BP; Archer GL
    Antimicrob Agents Chemother; 1998 Jun; 42(6):1355-60. PubMed ID: 9624475
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative bactericidal activity of penicillin-netilmicin and penicillin-gentamicin against enterococci.
    Rahal JJ; Simberkoff MS
    J Antimicrob Chemother; 1986 May; 17(5):585-91. PubMed ID: 3636323
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Successful therapy of experimental endocarditis caused by vancomycin-resistant Staphylococcus aureus with a combination of vancomycin and beta-lactam antibiotics.
    Fox PM; Lampen RJ; Stumpf KS; Archer GL; Climo MW
    Antimicrob Agents Chemother; 2006 Sep; 50(9):2951-6. PubMed ID: 16940087
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.